Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and in continuation of our earlier intimation dated August 14, 2025, please find enclosed herewith a copy of the media release titled "Sudarshan Pharma boosts Manufacturing Capacity with Strategic Investment in Operational API Facility, signs agreement with Srigen Lifesciences.